Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function-Reference-Cited by-同舟云学术

Safety and Efficacy of Eplerenone in Patients at High Risk for Hyperkalemia and/or Worsening Renal Function

Published:2013-10 Issue:17 Volume:62 Page:1585-1593
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Eschalier Romain,McMurray John J.V.,Swedberg Karl,van Veldhuisen Dirk J.,Krum Henry,Pocock Stuart J.,Shi Harry,Vincent John,Rossignol Patrick,Zannad Faiez,Pitt Bertram

Funder

Eugene Braunwald Endowment for the Advancement of Cardiovascular Discovery and Care

Pfizer

AstraZeneca

Daiichi Sankyo

Novartis

Roche

Takeda

Servier

Fresenius

Forest Laboratories

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference22 articles.

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators;Pitt;N Engl J Med,1999

2. Eplerenone in patients with systolic heart failure and mild symptoms;Zannad;N Engl J Med,2011

3. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction;Pitt;N Engl J Med,2003

4. Aliskiren, ALTITUDE, and the implications for ATMOSPHERE

5. Use of aldosterone antagonists in heart failure;Albert;JAMA,2009

Cited by 214 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequencing Quadruple Therapy for Heart Failure with Reduced Ejection Fraction: Does It Really Matter?;Heart Failure Clinics;2024-10

2. Management of patients with heart failure and chronic kidney disease;Heart Failure Reviews;2024-07-29

3. Mitigation of CXCL10 secretion by metabolic disorder drugs in microglial-mediated neuroinflammation;Journal of Neuroimmunology;2024-06

4. A Case-Based Implementation of Heart Failure Therapies, A Consensus Pathway by The Saudi Heart Failure Working Group;Journal of the Saudi Heart Association;2024-06-01

5. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC;European Journal of Heart Failure;2024-05-22